Canadian Pegvisomant Compassionate Study In Acromegalic Patients

NCT00151437 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: Pegvisomant treatment
PROCEDURE: Medical History, demographics
PROCEDURE: Sign and symptoms: questionnaire
PROCEDURE: Blood tests: IGF-1, AST/ALT/ALP/TBIL, GTT
PROCEDURE: MRI

Sponsor

Pfizer